Carregant...
Mitoxantrone as a Substitute for Daunorubicin During Induction in Newly Diagnosed Lymphoblastic Leukemia and Lymphoma
BACKGROUND: Daunorubicin, a component of the four-drug induction chemotherapy regimen for de novo pediatric high-risk acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LLy), was unavailable in 2011 due to a national drug shortage. During this time, our institution substituted mitoxantro...
Guardat en:
| Publicat a: | Pediatr Blood Cancer |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4317248/ https://ncbi.nlm.nih.gov/pubmed/24357218 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24892 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|